Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
clinical trials
fda
life sciences
national blog main
alprazolam
amgen
bial
boston blog main
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
drug development
drug enforcement administration
eli lilly
indiana
indiana blog main
indiana top stories
lasmiditan
migraine research foundation
neurocrine
neurodegeneration
neuroscience
opicapone
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
san diego
san diego blog main
san diego top stories
teva pharmaceutical
triptans
What
fda
2
×
medication
2
×
acute
add
addresses
approval
called
carbidopa
causes
combination
condition
control
daily
decades
disease
drug
eli
experience
friday
gets
giant
giving
lasmiditan
levodopa
lilly
lilly’s
migraine
neurocrine
new
nod
oks
parkinson’s
patients
pharmaceutical
pill
second
symptoms
time
won
Language
unset
Current search:
fda
×
medication
×
biotech
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
